PUBLICATIONS · 1450067
Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. An Eastern Cooperative Oncology Group study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 1992 Nov
- First author
- Falkson G
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Falkson G
- type
- Author
- name
- Gelman RS
- type
- Author
- name
- Glick J
- type
- Author
- name
- Falkson CI
- type
- Author
- name
- Harris J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Falkson G
- type
- Author
- name
- Gelman RS
- type
- Author
- name
- Glick J
- type
- Author
- name
- Falkson CI
- type
- Author
- name
- Harris J
- type
- Author
- bibliography ids
- nci-bib-6e5baef19e6e8ffa1bdcfaf2
- book metadata
- content sha256
- 92a82e3acfec7070cf1460b6ddc638c0bf2c61a4a33a85abf27ffefd0fc46a7a
- document type
- citation
- dois
- 10.1093/oxfordjournals.annonc.a058337
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:1450067
- immutable id
- pubmed:1450067@92a82e3acfec7070cf1460b6ddc638c0bf2c61a4a33a85abf27ffefd0fc46a7a
- journal
- abbreviation
- Ann Oncol
- issn electronic
- Source null
- issn print
- 0923-7534
- issue
- 9
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 768-70
- volume
- 3
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 1450067
- provenance
- batch id
- a0a1edf07d2c8b32d054
- provider
- NCBI PubMed ESummary
- record sha256
- fa739473b2d4d06e21f5cd69c99760d891a13c5bdee49927f7cc599fffb0b128
- response sha256
- 963b26e86e4619ee230bdf4421d4a6bcc6f03eee0a79718c660c7d40a3c066da
- retrieved at
- 2026-09-09T23:45:05.141944+00:00
- publication date
- display
- 1992 Nov
- precision
- month
- year
- 1992
- publication types
- Journal Article
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/1450067/
- title
- Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. An Eastern Cooperative Oncology Group study.
Preserved source evidence · Not medical advice
Triangle